Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Beyer

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nuclear Medicine and Biology|July 1, 1997
The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. The ISOLDE CollaborationG J Beyer, R Offord, G Künzi, et al.
Experimental Pathology|January 1, 1991
Investigations of cerebral glucose utilization into the newborn brain: a [18F]-FDG positron emission tomography study using a high resolution multiwire proportional chamber detector deviceR Bauer, R Bergmann, G J Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximabG-J Beyer, M Miederer, S Vranjes-Durić, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nuclear Medicine and Biology|July 1, 1997
The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. The ISOLDE CollaborationG J Beyer, R Offord, G Künzi, et al.
Experimental Pathology|January 1, 1991
Investigations of cerebral glucose utilization into the newborn brain: a [18F]-FDG positron emission tomography study using a high resolution multiwire proportional chamber detector deviceR Bauer, R Bergmann, G J Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximabG-J Beyer, M Miederer, S Vranjes-Durić, et al.
Pageof 2